KIEV, Nov. 3 – Medicine procurement by international organizations should not restrict the opportunities of Ukrainian manufacturers, whose products are to comprise 25% of public procurement, to participate in tenders, Director General of Interchem double liability company (Odessa) Anatoliy Reder has said.

"Around 25% of the range of medicines under state programs is made in Ukraine. For international organizations are able to buy these medicines, they must be reclassified by international organizations. If it occurs that Ukrainian medicines made under international standards must pass the reclassification procedure, then they are to be brought abroad, then international organizations could buy the medicine outside Ukraine, and then they bring back to Ukraine where it was made. It is not a hard, but absolutely destructive way," he said in an interview with Interfax-Ukraine.